Cornerstone Advisors (Washington)’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-209
| Closed | -$27K | – | 1474 |
|
|
2019
Q2 | $27K | Buy |
209
+78
| +60% | +$10.1K | ﹤0.01% | 582 |
|
|
2019
Q1 | $18K | Sell |
131
-324
| -71% | -$44.5K | ﹤0.01% | 626 |
|
|
2018
Q4 | $44K | Sell |
455
-77
| -14% | -$7.45K | 0.01% | 326 |
|
|
2018
Q3 | $74K | Sell |
532
-614
| -54% | -$85.4K | 0.05% | 255 |
|
|
2018
Q2 | $142K | Sell |
1,146
-98
| -8% | -$12.1K | 0.1% | 159 |
|
|
2018
Q1 | $139K | Sell |
1,244
-125
| -9% | -$14K | 0.09% | 156 |
|
|
2017
Q4 | $164K | Sell |
1,369
-230
| -14% | -$27.6K | 0.11% | 139 |
|
|
2017
Q3 | $224K | Sell |
1,599
-210
| -12% | -$29.4K | 0.15% | 93 |
|
|
2017
Q2 | $220K | Buy |
1,809
+632
| +54% | +$76.9K | 0.12% | 91 |
|
|
2017
Q1 | $143K | Hold |
1,177
| – | – | 0.08% | 148 |
|
|
2016
Q4 | $144K | Buy |
1,177
+213
| +22% | +$26.1K | 0.12% | 130 |
|
|
2016
Q3 | $118K | Buy |
964
+310
| +47% | +$37.9K | 0.1% | 150 |
|
|
2016
Q2 | $76K | Sell |
654
-17
| -3% | -$1.98K | 0.08% | 124 |
|
|
2016
Q1 | $93K | Buy |
671
+70
| +12% | +$9.7K | 0.1% | 114 |
|
|
2015
Q4 | $115K | Sell |
601
-784
| -57% | -$150K | 0.13% | 111 |
|
|
2015
Q3 | $217K | Sell |
1,385
-205
| -13% | -$32.1K | 0.19% | 91 |
|
|
2015
Q2 | $287K | Buy |
1,590
+372
| +31% | +$67.1K | 0.23% | 70 |
|
|
2015
Q1 | $211K | Hold |
1,218
| – | – | 0.16% | 105 |
|
|
2014
Q4 | $225K | Buy |
1,218
+1,209
| +13,433% | +$223K | 0.16% | 103 |
|
|
2014
Q3 | $1K | Sell |
9
-4
| -31% | -$444 | ﹤0.01% | 579 |
|
|
2014
Q2 | $2K | Hold |
13
| – | – | ﹤0.01% | 506 |
|
|
2014
Q1 | $2K | Buy |
+13
| New | +$2K | ﹤0.01% | 418 |
|